Organon (NYSE: OGN) reported Q2 EPS of $1.31, $0.34 better than the analyst estimate of $0.97. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Organon sees FY2023 revenue of $6.25-6.45 billion, versus the consensus of $6.28 billion.

For earnings history and earnings-related data on Organon (OGN) click here.